Barclays’s Definitive Healthcare DH Stock Holding History
Bought
Maintained
Sold
Other funds holding DH
BCM
Barclays's DH Position: Q3 2026 in Review
Barclays reduced its Definitive Healthcare (DH) stake by 86% in Q3 2026, selling an estimated $229K and leaving 44,670 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4622.
Barclays first reported a position in DH in Q1 2022 and has held it in 19 quarters since. The position peaked at $733K in Q4 2023. 97 funds tracked by Wall St. Rank hold DH as of Q3 2026.
- Barclays held 44,670 shares of Definitive Healthcare worth $40.4K as of Q3 2026.
- Barclays sold 279,000 Definitive Healthcare shares in Q3 2026, an estimated $229K.
- Definitive Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4622 holding.
- Barclays first reported a position in Definitive Healthcare in Q1 2022 and has held it in 19 quarters since.
- Barclays's Definitive Healthcare position peaked at $733K in Q4 2023.
- 97 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.